User profiles for Rebecca C. Ahrens-Nicklas
Rebecca Ahrens-NicklasVerified email at email.chop.edu Cited by 1385 |
Stimulation of entorhinal cortex–dentate gyrus circuitry is antidepressive
…, DR Richardson, CE Kang, RC Ahrens-Nicklas… - Nature medicine, 2018 - nature.com
Major depressive disorder (MDD) is considered a ‘circuitopathy’, and brain stimulation therapies
hold promise for ameliorating MDD symptoms, including hippocampal dysfunction. It is …
hold promise for ameliorating MDD symptoms, including hippocampal dysfunction. It is …
[HTML][HTML] Rapid and definitive treatment of phenylketonuria in variant-humanized mice with corrective editing
…, P Qu, WH Peranteau, RC Ahrens-Nicklas… - Nature …, 2023 - nature.com
Phenylketonuria (PKU), an autosomal recessive disorder caused by pathogenic variants in
the phenylalanine hydroxylase (PAH) gene, results in the accumulation of blood …
the phenylalanine hydroxylase (PAH) gene, results in the accumulation of blood …
[HTML][HTML] Brain branched-chain amino acids in maple syrup urine disease: implications for neurological disorders
J Xu, Y Jakher, RC Ahrens-Nicklas - International Journal of Molecular …, 2020 - mdpi.com
Maple syrup urine disease (MSUD) is an autosomal recessive disorder caused by decreased
activity of the branched-chain α-ketoacid dehydrogenase complex (BCKDC), which …
activity of the branched-chain α-ketoacid dehydrogenase complex (BCKDC), which …
[HTML][HTML] Multiple sulfatase deficiency: a disease comprising mucopolysaccharidosis, sphingolipidosis, and more caused by a defect in posttranslational modification
…, K Radhakrishnan, RC Ahrens-Nicklas - International journal of …, 2020 - mdpi.com
Multiple sulfatase deficiency (MSD, MIM #272200) is an ultra-rare disease comprising
pathophysiology and clinical features of mucopolysaccharidosis, sphingolipidosis and other …
pathophysiology and clinical features of mucopolysaccharidosis, sphingolipidosis and other …
[HTML][HTML] Newborn screening for Pompe disease: Pennsylvania experience
C Ficicioglu, RC Ahrens-Nicklas, J Barch… - International Journal of …, 2020 - mdpi.com
… mutation (c.-32-13T>G). A total of 16 patients were compound heterozygous, and 11 of
them carried the splice site mutation (c.-32-13T>G). Three cases were homozygous for c.2238G>…
them carried the splice site mutation (c.-32-13T>G). Three cases were homozygous for c.2238G>…
Precision therapy for a new disorder of AMPA receptor recycling due to mutations in ATAD1
RC Ahrens-Nicklas, GKE Umanah… - Neurology …, 2017 - AAN Enterprises
Objective: ATAD1 encodes Thorase, a mediator of α-amino-3-hydroxy-5-methylisoxazole-4-proprionate
(AMPA) receptor recycling; in this work, we characterized the phenotype …
(AMPA) receptor recycling; in this work, we characterized the phenotype …
Disruption of cardiac thin filament assembly arising from a mutation in LMOD2: A novel mechanism of neonatal dilated cardiomyopathy
RC Ahrens-Nicklas, CT Pappas, GP Farman… - Science …, 2019 - science.org
Neonatal heart failure is a rare, poorly-understood presentation of familial dilated cardiomyopathy
(DCM). Exome sequencing in a neonate with severe DCM revealed a homozygous …
(DCM). Exome sequencing in a neonate with severe DCM revealed a homozygous …
[PDF][PDF] Efficient in vivo prime editing corrects the most frequent phenylketonuria variant, associated with high unmet medical need
…, P Qu, K Musunuru, RC Ahrens-Nicklas… - The American Journal of …, 2023 - cell.com
The c.1222C>T (p.Arg408Trp) variant in the phenylalanine hydroxylase gene (PAH) is the
most frequent cause of phenylketonuria (PKU), the most common inborn error of metabolism. …
most frequent cause of phenylketonuria (PKU), the most common inborn error of metabolism. …
Biochemical signatures of disease severity in multiple sulfatase deficiency
…, MH Gelb, RC Ahrens‐Nicklas - Journal of Inherited …, 2024 - Wiley Online Library
Sulfatases catalyze essential cellular reactions, including degradation of glycosaminoglycans
(GAGs). All sulfatases are post‐translationally activated by the formylglycine generating …
(GAGs). All sulfatases are post‐translationally activated by the formylglycine generating …
Drug screening identifies tazarotene and bexarotene as therapeutic agents in multiple sulfatase deficiency
…, K Tyka, M Kettwig, RC Ahrens‐Nicklas… - EMBO Molecular …, 2023 - embopress.org
Multiple sulfatase deficiency (MSD, MIM #272200) results from pathogenic variants in the
SUMF1 gene that impair proper function of the formylglycine‐generating enzyme (FGE). FGE is …
SUMF1 gene that impair proper function of the formylglycine‐generating enzyme (FGE). FGE is …